Abstract:Background: Breast cancer (BC) continues to have the second highest mortality amongst women in the United States after lung cancer. For 2021, the American Cancer Association predicted 281,550 new invasive breast cancer cases besides 49,290 new cases of non-invasive breast cancer and 43,600 deaths from the metastatic disease. A treatment modality is radiation therapy, which is given for local control as well as palliation of patient symptoms. The initial step of new drug development is in-vitro cell studies, which help describe new drug properties and toxicities. However, these models are not optimal, and better ones have yet to be determined. This study uses bioprinting technology to elucidate the sensitivity of tumor cells to the combination of palbociclib (PD) and letrozole (Let) treatment. We hypothesize that this technology could serve as a model to predict treatment outcomes more efficiently. Methods: The breast cancer cell lines MCF7 and MDA-MB-231 as well as the normal breast epithelial cell line, MCF-10A, were treated with PD-Let with and without radiotherapy (RT), and cell viability was compared in pairwise fashion for thermally inkjet bioprinted (TIB) and manually seeded (MS) cells. Results: In absence of radiation, the TIB MCF7 cells have 2.5 times higher viability than manually seeded (MS) cells when treated with 100 μM palbociclib and 10 μM letrozole, a 36% higher viability when treated with 50 μM palbociclib and 10 μM letrozole, and an 8% higher viability when treated with 10 μM palbociclib and 10 μM letrozole. With 10 Gy of radiation, TIB cells had a 45% higher survival rate than MS cells at the lowest palbociclib concentration and a 29% higher survival rate at the intermediate palbociclib concentration. Without radiation treatment, at a concentration of 10 μM PD-Let, TIB MDA-MB-231 cells show a 8% higher viability than MS cells when treated with 10 μM PD and 10 μM Let; at higher drug concentrations, the differences disappeared, but some 1.7% of the TIB MDA-MB-231 cells survived exposure to 150 μM of PD + 10 μM letrozole vs. none of the MS cells. These cells are more radiation sensitive than the other cell lines tested and less sensitive to the combo drug treatments. We observed an 18% higher survival of TIB MCF-10A cells without radiation treatment when exposed to 10 μM PD + 10 μM Let but no difference in cell survival between the two groups when radiation was applied. Independent of growth conditions, TIB cells did not show more resistance to radiation treatment than MS cells, but a higher resistance to the combo treatment was observed, which was most pronounced in the MCF-7 cell line. Conclusion: Based on these results, we suggest that TIB used in in-vitro models could be a feasible strategy to develop and/or test new anticancer drugs.

Chemo-treated 4T1 breast cancer cells radiation response measured by single and multiple cell ionization using infrared laser trap

Determination of surface temperature distribution in biological tissues during laser-immunotherapy

Comparison of Cellular Damage Response to Low-Dose-rate 125I Seed Irradiation and High-Dose-rate Gamma Irradiation in Human Lung Cancer Cells

Radiofrequency Heat-Enhanced Chemotherapy for Breast Cancer: Towards Interventional Molecular Image-Guided Chemotherapy.

Effect of radiation treatment on newly established human breast cancer cell lines MACL-1 and MGSO-3

Tissue Temperature Distribution Measurement and Laser Immunotherapy for Cancer Treatment

The Correlation Study of Temperature Distribution with the Immunology Response under Laser Radiation

Thermal damage of tissue during near-infrared laser irradiation with assistance of light-absorbing dye

Comparison of Radiation Response between 2D and 3D Cell Culture Models of Different Human Cancer Cell Lines

The Effect of Photobiomodulation on the Conditioned Media of 3T3-L1 Cells in the Treatment of Breast Cancer

Densely Ionizing Radiation Acts Via The Microenvironment To Promote Aggressive Trp53-Null Mammary Carcinomas

The cytotoxicity of breast cancer mcf-7 cell line treated with different wavelength of low-level laser

Tissue temperature distribution measurement by MRI and laser immunology for cancer treatment

Thermal infrared image to quantify nano particles enhanced laser deposition during malignant tissue ablation

Raman profile alterations of irradiated human nasopharyngeal cancer cells detected with laser tweezer Raman spectroscopy

A Raman spectroscopic study of cell response to clinical doses of ionizing radiation

Assessment of the Efficacy of Laser Hyperthermia and Nanoparticle-Enhanced Therapies by Heat Shock Protein Analysis

Detection of Treatment Response in Triple‐Negative Breast Tumors to Paclitaxel Using MRI Cell Size Imaging

Novel Combinatorial Strategy Using Thermal Inkjet Bioprinting, Chemotherapy, and Radiation on Human Breast Cancer Cells; an In-Vitro Cell Viability Assessment

Determination of radiosensitivity from chest X-ray on human breast cancer cell line MDA-MB-231 in terms of cell morphology and cell proliferation

Comparative study of immune response to local tumor destruction modalities in a murine breast cancer model